Erlichman C - Search Results

1

Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors.

Hobday TJ, Qin R, Reidy-Lagunes D, Moore MJ, Strosberg J, Kaubisch A, Shah M, Kindler HL, Lenz HJ, Chen H, Erlichman C. Hobday TJ, et al. Among authors: erlichman c. J Clin Oncol. 2015 May 10;33(14):1551-6. doi: 10.1200/JCO.2014.56.2082. Epub 2014 Dec 8. J Clin Oncol. 2015. PMID: 25488966 Free PMC article. Clinical Trial.

2

Phase I pharmacokinetic and pharmacodynamic study of a new anthrapyrazole, CI-937 (DUP937).

Erlichman C, Moore M, Kerr IG, Wong B, Eisenhauer E, Zee B, Whitfield LR. Erlichman C, et al. Cancer Res. 1991 Dec 1;51(23 Pt 1):6317-22. Cancer Res. 1991. PMID: 1933893 Clinical Trial.

3

Phase I/II trial of granisetron: a novel 5-hydroxytryptamine antagonist for the prevention of chemotherapy-induced nausea and vomiting.

Addelman M, Erlichman C, Fine S, Warr D, Murray C. Addelman M, et al. Among authors: erlichman c. J Clin Oncol. 1990 Feb;8(2):337-41. doi: 10.1200/JCO.1990.8.2.337. J Clin Oncol. 1990. PMID: 2153767

4

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

Tannock IF, Boyd NF, DeBoer G, Erlichman C, Fine S, Larocque G, Mayers C, Perrault D, Sutherland H. Tannock IF, et al. Among authors: erlichman c. J Clin Oncol. 1988 Sep;6(9):1377-87. doi: 10.1200/JCO.1988.6.9.1377. J Clin Oncol. 1988. PMID: 2458438 Clinical Trial.

5

Rapid development of enhanced clearance after high-dose cyclophosphamide.

Moore MJ, Hardy RW, Thiessen JJ, Soldin SJ, Erlichman C. Moore MJ, et al. Among authors: erlichman c. Clin Pharmacol Ther. 1988 Dec;44(6):622-8. doi: 10.1038/clpt.1988.203. Clin Pharmacol Ther. 1988. PMID: 3058371

6

A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.

Erlichman C, Fine S, Wong A, Elhakim T. Erlichman C, et al. J Clin Oncol. 1988 Mar;6(3):469-75. doi: 10.1200/JCO.1988.6.3.469. J Clin Oncol. 1988. PMID: 3280741 Clinical Trial.

7

Therapeutic drug monitoring in oncology. Problems and potential in antineoplastic therapy.

Moore MJ, Erlichman C. Moore MJ, et al. Among authors: erlichman c. Clin Pharmacokinet. 1987 Oct;13(4):205-27. doi: 10.2165/00003088-198713040-00001. Clin Pharmacokinet. 1987. PMID: 3311530 Review.

8

A clinical and pharmacological study of 5-fluorouracil, leucovorin and interferon alfa in advanced colorectal cancer.

Moore MJ, Kaizer L, Erlichman C, Myers R, Feld R, Thiessen JJ, Fine S. Moore MJ, et al. Among authors: erlichman c. Cancer Chemother Pharmacol. 1995;37(1-2):86-90. doi: 10.1007/BF00685633. Cancer Chemother Pharmacol. 1995. PMID: 7497602 Clinical Trial.

9

Variability in the pharmacokinetics of cyclophosphamide, methotrexate and 5-fluorouracil in women receiving adjuvant treatment for breast cancer.

Moore MJ, Erlichman C, Thiessen JJ, Bunting PS, Hardy R, Kerr I, Soldin S. Moore MJ, et al. Among authors: erlichman c. Cancer Chemother Pharmacol. 1994;33(6):472-6. doi: 10.1007/BF00686503. Cancer Chemother Pharmacol. 1994. PMID: 8137456

10

A phase II study of 5-fluorouracil, leucovorin and interferon-alpha in advanced pancreatic cancer.

Moore MJ, Erlichman C, Kaizer L, Fine S. Moore MJ, et al. Among authors: erlichman c. Anticancer Drugs. 1993 Oct;4(5):555-7. doi: 10.1097/00001813-199310000-00004. Anticancer Drugs. 1993. PMID: 8292812 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

243 results

Search Page

Filters